Helen Of Troy Analysts Cut Their Forecasts Following Q2 Earnings

Helen Of Troy (HELE) reported mixed second-quarter results, with adjusted EPS of $0.59 (down 51.2%) and sales of $431.8 million (down 8.9%) both exceeding analyst estimates. However, the company issued a cautious outlook for Q3 and fiscal year 2026, citing persistent cost pressures and tariff-related disruptions, with its full-year EPS guidance of $3.75-$4.25 falling below consensus. Following the announcement, shares saw a slight decline, and analysts from Canaccord Genuity and UBS lowered their price targets while maintaining neutral ratings, reflecting concerns over future profitability.

Analysis

Helen Of Troy Limited (HELE) reported a significant 51.2% year-over-year decline in Q2 adjusted EPS to $0.59, despite beating the analyst consensus of $0.53. Quarterly sales also decreased by 8.9% year-over-year to $431.8 million, surpassing the street's expectation of $418.8 million. This mixed performance, characterized by revenue and EPS beats against substantial Y/Y declines, signals underlying operational challenges.

The company issued a cautious outlook, projecting Q3 adjusted EPS of $1.55-$1.80 and fiscal year 2026 adjusted EPS of $3.75-$4.25, both falling below analyst estimates of $1.98 and $4.58, respectively. Management cited persistent cost pressures and tariff-related disruptions as key headwinds expected to impact results through fiscal 2026. This forward guidance suggests continued profitability challenges despite slightly better-than-expected sales guidance for FY26.

Following the announcement, HELE shares experienced a marginal decline of 0.2% to $20.66. Analysts from Canaccord Genuity and UBS responded by lowering their price targets from $26 to $23 and $27 to $25, respectively, while maintaining Hold/Neutral ratings. This adjustment reflects a tempered outlook on future valuation potential, primarily driven by the revised, lower earnings guidance and ongoing operational concerns.

Key Decisions for Investors

• Investors should closely monitor the company's ability to mitigate persistent cost pressures and tariff impacts, as these are key drivers of the lowered fiscal 2026 EPS guidance.
• Given the analyst price target reductions and maintained neutral ratings, a cautious stance on HELE may be warranted until there is clearer visibility on margin stabilization and earnings recovery.
• Evaluate the potential for further downside risk if the company fails to meet its revised, lower guidance or if macroeconomic conditions exacerbate existing headwinds.